Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-02-28

Clinical Trial Update: To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics. [NA]

View source ↗

Summary

A clinical trial update comparing lactulose with polyethylene glycol for overt hepatic encephalopathy in patients with cirrhosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LACTULOSE (Lactulose)
  • Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Cirrhosis | NA | Status: UNKNOWN